Compare PRQR & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Launch One Acquisition Corp is a blank check company.